Detta stycke finns inte på svenska, därför visas den engelska versionen.
Our research is focused on understanding the molecular mechanisms behind Alzheimer's disease and other types of dementia. We have generated antibodies that bind specifically to different forms of Aβ or α-synuclein. Some of the antibodies have also been modified to bind the transferrin receptor (TfR), which is normally involved in iron transport into the brain. The interaction with TfR works like a molecular Trojan horse, which transports the antibody into the brain, where it can bind to its target. This modification increases antibody brain concentration up to 100-fold. These bispecific antibodies have been explored as novel PET radioligands and as immunotherapeutics.
In parallel with the development of brain penetrant antibodies we study changes in the blood-brain barrier (BBB) during neurodegeneration. We also use small molecule PET radioligands to investigate pathology in the ageing brain focusing mainly on protein deposits, neuroinflammation and synaptic dysfunction..
Kontakta katalogansvarig vid den aktuella organisationen (institution eller motsv.) för att rätta ev. felaktigheter.